^"Human PubMed Reference:".National Center for Biotechnology Information, U.S. National Library of Medicine.
^Berdoz J, Tiercy JM, Rollini P, Mach B, Gorski J (May 1989). "Remarkable sequence conservation of the HLA-DQB2 locus (DX beta) within the highly polymorphic DQ subregion of the human MHC".Immunogenetics.29 (4):241–8.doi:10.1007/BF00717908.PMID2564844.S2CID8196719.
Piatier-Tonneau D, Gastinel LN, Amblard F, et al. (1991). "Interaction of CD4 with HLA class II antigens and HIV gp120".Immunogenetics.34 (2):121–8.doi:10.1007/BF00211424.PMID1869305.S2CID10116507.
Andrieu JM, Even P, Venet A (1986). "AIDS and related syndromes as a viral-induced autoimmune disease of the immune system: an anti-MHC II disorder. Therapeutic implications".AIDS Research.2 (3):163–74.doi:10.1089/aid.1.1986.2.163.PMID3489470.
Rowell JF, Stanhope PE, Siliciano RF (1995). "Endocytosis of endogenously synthesized HIV-1 envelope protein. Mechanism and role in processing for association with class II MHC".J. Immunol.155 (1):473–88.doi:10.4049/jimmunol.155.1.473.PMID7602119.S2CID19994352.
Chen YH, Böck G, Vornhagen R, et al. (1994). "HIV-1 gp41 binding proteins and antibodies to gp41 could inhibit enhancement of human Raji cell MHC class I and II expression by gp41".Mol. Immunol.31 (13):977–82.doi:10.1016/0161-5890(94)90092-2.PMID8084338.
Beck S, Abdulla S, Alderton RP, et al. (1996). "Evolutionary dynamics of non-coding sequences within the class II region of the human MHC".J. Mol. Biol.255 (1):1–13.doi:10.1006/jmbi.1996.0001.PMID8568858.